Ernexa Therapeutics Inc.: Form SC 13D, filed Nov 21, 2018
Filed with the SEC on Nov 21, 2018 and accepted by EDGAR at Nov 21, 2018, 14:13 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001062993-18-004781. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.